Praised for being ‘professional and responsive,’ Zhong Lun Law Firm’s capabilities include financing, domestic and overseas IPOs, and medical products regulation, as well as compliance, licensing, and intellectual property issues. Overseeing the department are Changyu Fu, who brings experience in dispute resolution and anti-trust, and Helen Cheng. Dongmei Wang leads the healthcare team, while Jim Qiu and Shaun Gao direct the pharmaceuticals and life sciences group. Yuru Zuo is sought after by pharmaceutical companies for her product liability, clinical trials, and approval of human legacy knowledge, and Qi Lan stands out for her patent prosecution, invalidation, and litigation expertise.
Legal 500 redaktioneller Kommentar
- Profil
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
‘Professional and responsive, with deep involvement of partners.’
‘Xin Gao is professional and strives for the best interests of the client based on the actual situation, with a long-term vision.'
‘Zhong Lun Law Firm has a wide range of businesses. When a company encounters legal issues, it can look for lawyers to cooperate within this comprehensive firm, such as customs control, compliance, labour and personnel, etc.’
‘Jim Qiu's team is very professional and has excellent English. They have assisted our company in completing many businesses, such as CSO contracts and cross-border e-commerce.’
Kernmandanten
- Rejukon Biopharm Inc.
- Yantai DongCheng HYL Healthcare Group Co., Ltd
- Microline Surgical, Inc.
- Yantai Yitai Pharmaceutical Technology Co., Ltd.
- OrbiMed
- I-Mab Hangzhou
- Boyu Capital
- Cutia
- Hasten Biopharmaceutic
- Shanghai Medical Group Joint Administration Development Center
Highlight-Mandate
Represented Microline Surgical in its acquisition of a liver retractor business from a US company.
Provided long-term legal services for Shanghai Medical Group Joint Administration Development Center in respect of legal medical compliance advisory and review of medical contracts.
Advised Sino-Jin Gongying Qijiang (Shanghai) Kechuang Equity Investment Fund Partnership & CNNC Industry Fund Management Corporation on legal due diligence of Simopharm Holdings Chuangfu Medical Technology (Shanghai) Co., Ltd.
Anwält*innen
Führende Partner*innen
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.
Partner*innen der nächsten Generation
Juniorpartner*innen, die im Markt von Mandanten und Wettbewerbern anerkannt werden und in einigen Mandaten eine Schlüsselrolle einnehmen.
Qi Lan
Jim Qiu
Yuru Zuo
Führende Associates
Führende Associates sind regelmäßig an zentralen Mandaten des Teams beteiligt und erhalten positives Feedback von Wettbewerbern oder Mandanten.
Shuman Zhang
Praxisleitung
Helen Cheng; Changyu Fu; Dongmei Wang; Jim Qiu; Shaun Gao
Weitere Kernanwält*innen
Qi Lan; Yuru Zuo; Shuman Zhang; Julia Zhu